Free Trial
NYSE:BAX

Baxter International (BAX) Stock Price, News & Analysis

Baxter International logo
$29.50 +0.60 (+2.08%)
(As of 12/20/2024 05:31 PM ET)

About Baxter International Stock (NYSE:BAX)

Key Stats

Today's Range
$29.17
$29.99
50-Day Range
$28.90
$36.91
52-Week Range
$28.62
$44.01
Volume
12.19 million shs
Average Volume
4.17 million shs
Market Capitalization
$15.06 billion
P/E Ratio
147.51
Dividend Yield
2.31%
Price Target
$40.45
Consensus Rating
Hold

Company Overview

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Baxter International Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
91st Percentile Overall Score

BAX MarketRank™: 

Baxter International scored higher than 91% of companies evaluated by MarketBeat, and ranked 101st out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Baxter International has received a consensus rating of Hold. The company's average rating score is 2.18, and is based on 3 buy ratings, 7 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Baxter International has only been the subject of 2 research reports in the past 90 days.

  • Read more about Baxter International's stock forecast and price target.
  • Earnings Growth

    Earnings for Baxter International are expected to grow by 28.65% in the coming year, from $1.92 to $2.47 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Baxter International is 147.51, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 112.76.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Baxter International is 147.51, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 87.03.

  • Price to Earnings Growth Ratio

    Baxter International has a PEG Ratio of 12.74. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Baxter International has a P/B Ratio of 1.77. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.42% of the outstanding shares of Baxter International have been sold short.
  • Short Interest Ratio / Days to Cover

    Baxter International has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Baxter International has recently decreased by 3.28%, indicating that investor sentiment is improving.
  • Dividend Yield

    Baxter International pays a meaningful dividend of 2.29%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Baxter International does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Baxter International is 340.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on earnings estimates, Baxter International will have a dividend payout ratio of 27.53% next year. This indicates that Baxter International will be able to sustain or increase its dividend.

  • Read more about Baxter International's dividend.
  • Percentage of Shares Shorted

    2.42% of the outstanding shares of Baxter International have been sold short.
  • Short Interest Ratio / Days to Cover

    Baxter International has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Baxter International has recently decreased by 3.28%, indicating that investor sentiment is improving.
  • News Sentiment

    Baxter International has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Baxter International this week, compared to 8 articles on an average week.
  • Search Interest

    Only 9 people have searched for BAX on MarketBeat in the last 30 days. This is a decrease of -18% compared to the previous 30 days.
  • MarketBeat Follows

    Only 6 people have added Baxter International to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Baxter International insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.21% of the stock of Baxter International is held by insiders.

  • Percentage Held by Institutions

    90.19% of the stock of Baxter International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Baxter International's insider trading history.
Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

BAX Stock News Headlines

Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference
This is the worst sign for the U.S. stock market in 50 years
The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"
Baxter price target lowered to $35 from $37 at Citi
See More Headlines

BAX Stock Analysis - Frequently Asked Questions

Baxter International's stock was trading at $38.66 at the beginning of the year. Since then, BAX shares have decreased by 23.7% and is now trading at $29.50.
View the best growth stocks for 2024 here
.

Baxter International Inc. (NYSE:BAX) announced its quarterly earnings data on Friday, November, 8th. The medical instruments supplier reported $0.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.78 by $0.02. The business's revenue was up 3.8% on a year-over-year basis.
Read the conference call transcript
.

The following companies are subsidiaries of Baxter International: Cheetah Medical, ApaTech Limited, Baxter AO, Baxter Belgium SPRL, Baxter (China) Investment Co. Ltd, Baxter Company Ltd, Baxter Corporation (Canada), and others.

Baxter International's top institutional investors include Geode Capital Management LLC (2.38%), Thompson Siegel & Walmsley LLC (0.37%), Coho Partners Ltd. (0.30%) and National Pension Service (0.23%). Insiders that own company stock include Jeanne K Mason, Albert P L Stroucken, Jacqueline Kunzler and Brian Stevens.
View institutional ownership trends
.

Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Baxter International investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Exxon Mobil (XOM), Chevron (CVX), JPMorgan Chase & Co. (JPM) and Intel (INTC).

Company Calendar

Ex-Dividend for 10/1 Dividend
8/30/2024
Dividend Payable
10/01/2024
Last Earnings
11/08/2024
Ex-Dividend for 1/2 Dividend
11/29/2024
Today
12/22/2024
Fiscal Year End
12/31/2024
Dividend Payable
1/02/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
CUSIP
07181310
Employees
60,000
Year Founded
1931

Price Target and Rating

Average Stock Price Target
$40.45
High Stock Price Target
$54.00
Low Stock Price Target
$30.00
Potential Upside/Downside
+37.1%
Consensus Rating
Hold
Rating Score (0-4)
2.18
Research Coverage
11 Analysts

Profitability

Net Income
$2.66 billion
Pretax Margin
-0.50%

Debt

Sales & Book Value

Annual Sales
$15.06 billion
Cash Flow
$4.99 per share
Book Value
$16.69 per share

Miscellaneous

Free Float
509,516,000
Market Cap
$15.06 billion
Optionable
Optionable
Beta
0.57

Social Links

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

This page (NYSE:BAX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners